GUIDA della Società

Guida al software di supporto alle decisioni cliniche della FDA

FDA’s Clinical Decision Support Software guidance explains when software functions may be regulated as medical devices and when a non-device CDS exclusion may apply.

Ascolta questa guidaNarrato dall'IA · ~3 min

In questa pagina3 minuti di lettura
  1. Panoramica
  2. Immersione profonda
  3. Implementazione nel mondo reale
  4. The Future of FDA Clinical Decision Support Software Guidance
  5. Metterlo in pratica
  6. Continua a esplorare
  7. Domande frequenti

Panoramica

The analysis depends on the function, intended user, and ability of a health professional to independently review the basis for recommendations. These distinctions require function-specific review, not assumptions based on a product’s “CDS” label.

Immersione profonda

Clinical decision support software provides information or recommendations to support healthcare decisions. FDA’s guidance explains how the agency assesses software functions under the applicable statutory criteria. Some functions may be excluded from the device definition when they meet specific conditions, including that a health professional can independently review the basis for recommendations. Other functions, including certain patient-specific analyses or device functions, may remain subject to oversight. The assessment is about what a particular software function does, its intended user, and how the output is used. A product can contain multiple functions with different regulatory status. A tool that presents evidence for a clinician to review is not automatically treated the same as software that directs diagnosis or treatment. FDA guidance also notes that functions intended for patients or caregivers may be assessed differently from clinician-facing support. Manufacturers should define each function and provide information that supports independent review where relevant. Clinicians should understand what inputs and evidence support a recommendation, the intended population, and limitations. A generated explanation is not itself proof of the underlying basis. Check current FDA guidance and product labeling for the specific function. This guide summarizes concepts and does not determine regulatory status for a product. Preserve examples of intended use and evidence that support the analysis, and revisit it when users, claims, or outputs change. Keep patient-facing and clinician-facing functions distinct in requirements and documentation.

Implementazione nel mondo reale

A clinician reviews sources and rationale behind a recommendation before acting.

A software team separates administrative reminders from patient-specific treatment recommendations.

A hospital confirms whether a function is intended for health professionals or patients.

A developer maps the product’s intended use to the criteria in current FDA guidance.

The Future of FDA Clinical Decision Support Software Guidance

Decision-support products increasingly use machine learning and generative models, creating new questions about explainability and how clinicians review evidence. FDA guidance is updated as laws and technology change. Developers should monitor current agency materials and preserve a function-level analysis. Care teams need training to interpret outputs and should retain clinical judgment even when a tool is authorized. Developers should design interfaces that make the evidence and limitations easy to inspect, not merely generate a plausible explanation. Monitor outcomes and user feedback.

Metterlo in pratica

Perché è importante

  • Rischio e sicurezza. I danni catastrofici e quotidiani dell’IA dipendono entrambi da chi comprende i rischi e da chi può agire.
  • Decisioni più chiare. L’alfabetizzazione pubblica e professionale determina la possibilità politica di una forte politica di sicurezza.
  • Tagliare il clamore. Spiegazioni chiare riducono la cattura da parte di montature pubblicitarie, PR di laboratorio e vaghi teatrini etici.

Attenzione

  • Trattare il rischio esistenziale come fantascienza mentre le capacità si aggravano.
  • Confondere la sicurezza del prodotto superficiale con l'allineamento in condizioni di elevata autonomia.
  • Lasciando il pubblico non inglese e non esperto solo con fonti di bassa qualità.

Prossimi passi

  1. Separare i rischi di danni al prodotto, uso improprio e perdita di controllo/disallineamento.
  2. Chiedi quali prove cambierebbero la tua opinione sulle tempistiche e sulla gravità.
  3. Preferire fonti primarie e valutazioni concrete alle affermazioni di marketing.
  4. Identifica un percorso d’azione: carriera, politica, finanziamenti o competenze, non solo consapevolezza.

Continua a esplorare

Newsletter gratuita

Ricevi il briefing quotidiano sull'IA

Tre storie verificate sull'IA ogni mattina nei giorni feriali, scritte in un inglese semplice. Gratuito per sempre, senza pubblicità.

Un'email ogni giorno feriale. Disiscriviti con un clic. Non vendiamo né condividiamo mai il tuo indirizzo.

Mettiti alla prova

Take the FDA Clinical Decision Support Software Guidance quiz

Feedback immediato su ogni risposta e un certificato condivisibile con un ID verificabile una volta superato un corso.

Inizia il quiz

Sostieni l'istruzione gratuita sull'IA. AI Understanding è un'organizzazione non profit 501(c)(3) — nessun annuncio, nessun paywall, mai. Fai una donazione

Domande frequenti

What is FDA Clinical Decision Support Software Guidance?

FDA’s Clinical Decision Support Software guidance explains when software functions may be regulated as medical devices and when a non-device CDS exclusion may apply. The analysis depends on the function, intended user, and ability of a health professional to independently review the basis for recommendations. These distinctions require function-specific review, not assumptions based on a product’s “CDS” label.

What does FDA evaluate in clinical decision-support software?

Regulatory analysis depends on the function and how it is used.

Why analyze a product function by function?

Regulatory assessment is not necessarily product-wide and uniform.

What should developers document for a function?

Function-specific documentation supports assessment and use.

What should clinicians do with a CDS recommendation?

CDS supports decisions and does not replace professional review.